每經AI快訊，九(jiu)典制藥（SZ 300705，收(shou)盤價(jia)：26.25元）11月1日(ri)(ri)晚間發布公(gong)(gong)告稱(cheng)，持(chi)(chi)有公(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)約4856萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)司(si)(si)(si)(si)總(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)比例為(wei)(wei)14.78%）的(de)(de)持(chi)(chi)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)5%以上(shang)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)東(dong)(dong)段立新女(nv)(nv)士(shi)，計(ji)(ji)劃(hua)(hua)通過競價(jia)交易、大宗交易及法律、法規(gui)允許的(de)(de)其他方式減(jian)(jian)持(chi)(chi)公(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)不超過約657萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)司(si)(si)(si)(si)總(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)比例為(wei)(wei)2%）。持(chi)(chi)有公(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)約230萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)司(si)(si)(si)(si)總(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)比例為(wei)(wei)0.7%）的(de)(de)公(gong)(gong)司(si)(si)(si)(si)控股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)東(dong)(dong)一(yi)致行(xing)動人(ren)朱(zhu)志(zhi)云女(nv)(nv)士(shi)，計(ji)(ji)劃(hua)(hua)在本(ben)(ben)(ben)(ben)減(jian)(jian)持(chi)(chi)計(ji)(ji)劃(hua)(hua)公(gong)(gong)告披(pi)露(lu)日(ri)(ri)起15個交易日(ri)(ri)后的(de)(de)任意連(lian)續90日(ri)(ri)內(nei)，以集中(zhong)競價(jia)方式減(jian)(jian)持(chi)(chi)公(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)不超過約57萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)司(si)(si)(si)(si)總(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)比例為(wei)(wei)0.17%）。持(chi)(chi)有公(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)約175萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)司(si)(si)(si)(si)總(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)比例為(wei)(wei)0.53%）的(de)(de)公(gong)(gong)司(si)(si)(si)(si)控股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)東(dong)(dong)一(yi)致行(xing)動人(ren)朱(zhu)志(zhi)純女(nv)(nv)士(shi)，計(ji)(ji)劃(hua)(hua)在本(ben)(ben)(ben)(ben)減(jian)(jian)持(chi)(chi)計(ji)(ji)劃(hua)(hua)公(gong)(gong)告披(pi)露(lu)日(ri)(ri)起15個交易日(ri)(ri)后的(de)(de)任意連(lian)續90日(ri)(ri)內(nei)，以集中(zhong)競價(jia)方式減(jian)(jian)持(chi)(chi)公(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)份(fen)(fen)不超過約44萬(wan)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)（占(zhan)(zhan)公(gong)(gong)司(si)(si)(si)(si)總(zong)(zong)股(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)(gu)本(ben)(ben)(ben)(ben)比例為(wei)(wei)0.13%）。

2021年1至(zhi)12月份，九典制藥的營業收入構成(cheng)為：醫(yi)藥制造業占(zhan)比99.95%。

九典制藥的董(dong)事長是(shi)朱志宏，男，60歲，學歷背(bei)景為(wei)碩(shuo)士；總經理是(shi)鄭霞輝，男，61歲，學歷背(bei)景為(wei)本(ben)科。

截至(zhi)發稿，九典制藥市值為86億元。

道達號（daoda1997）“個股趨(qu)勢”提醒：
1. 近30日內共有1批機構對九典制藥調研，合計調研的機構家數為11家；
2. 九典制藥上次發布減持公告是2022年10月27日，第二個交易日下跌1.28%，九典制藥近一年共發布5次減持類公告。
更(geng)多個股趨(qu)勢信息，請搜索微信公眾號(hao)(hao)“道(dao)達(da)號(hao)(hao)”，回復“查(cha)詢(xun)”，領取免費(fei)查(cha)詢(xun)權限！

每經頭條(tiao)（nbdtoutiao）——

(記者 張楊運)

免責聲明：本文(wen)內容與數據僅供參考，不(bu)構成投資建議，使(shi)用前(qian)請核(he)實。據此操作，風險(xian)自擔。